Trial
NCT03679845
Study to Assess Sarilumab in Halting Progression of Morphea
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Massachusetts General Hospital
Collaborators
Regeneron Pharmaceuticals
Condition
Morphea, Plaque Form
Intervention
Sarilumab
Why stopped
Difficulty in recruiting patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-09-08